Tabanelli et al. Journal of Medical Case Reports 2011, 5:218 http://www.jmedicalcasereports.com/content/5/1/218 Authors’ contributions VT performed research, analyzed data and wrote the manuscript; CA performed research and analyzed data; ES and FB analyzed data; SC and GM were responsible for patient care and provided clinical information; AG, CM, SR, and MTS analyzed data; SAP and PPP performed research, analyzed data and wrote the manuscript. All authors read and approved the final manuscript. VT and CA contributed equally to this work; SAP and PPP contributed equally to this work. Competing interests The authors declare that they have no competing interests. Received: 18 August 2010 Accepted: 7 June 2011 Published: 7 June 2011 References 1. Straus SE, Cohen JI, Tosato G, Meier J: NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 1993, 118:45-58. 2. Callan MF, Steven N, Krausa P, Wilson JD, Moss PA, Gillespie GM, Bell JI, Rickinson AB, McMichael AJ: Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat Med 1996, 2:906-911. 3. Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK: Proposed categorization of pathological states of EBV-associated T/ natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 2008, 58:209-217. 4. Carbone A, Gloghini A, Dotti G: EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 2008, 13:577-585. 5. Quintanilla-Martinez L, Kimura H, Jaffe E: EBV+ T-cell lymphoproliferative disorders of childhood. In WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.. 4 edition. Edited by: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman J. Lyon: IARC; 2008:278-280. 6. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES: Fulminant EBV(+) T- cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 2000, 96:443-451. 7. Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S: Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001, 98:1882-1888. 8. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC: Epstein-Barr virus (EBV) infects T lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol 1994, 144:1219-1225. 9. van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, García-Sanz R, van Krieken JH, Droese J, González D, Bastard C, White HE, Spaargaren M, González M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA: Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003, 17:2257-2317. 10. Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S, Sabattini E, Bacci F, Falini B, Motta T, Paulli M, Artusi T, Piccioli M, Zinzani PL, Pileri SA: Marker expression in peripheral T-cell lymphoma: a proposed clinical- pathologic prognostic score. J Clin Oncol 2006, 24:2472-2479. 11. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J: T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. New Engl J Med 1988, 318:733-741. 12. Dolezal MV, Kamel OW, van de Rijn M, Cleary ML, Sibley RK, Warnke RA: Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol 1995, 103:189-194. 13. Gaillard F, Mechinaud-Lacroix F, Papin S, Moreau A, Mollat C, Fiche M, Peltier S, De Faucal PJ, Rousselet MC, Praloran V, et al: Primary Epstein-Barr virus infection with clonal T-cell lymphoproliferation. Am J Clin Pathol 1992, 98:324-333. 14. Wick MJ, Woronzoff-Dashkoff KP, McGlennen RC: The molecular characterization of fatal infectious mononucleosis. Am J Clin Pathol 2002, 117:582-588. Page 5 of 5 15. Craig FE, Gulley ML, Banks PM: Posttransplantation lymphoproliferative disorders. American journal of clinical pathology 1993, 99:265-276. doi:10.1186/1752-1947-5-218 Cite this article as: Tabanelli et al.: Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature. Journal of Medical Case Reports 2011 5:218. Submit your next manuscript to BioMed Central and take full advantage of: • Convenient online submission • Thorough peer review • No space constraints or color ﬁgure charges • Immediate publication on acceptance • Inclusion in PubMed, CAS, Scopus and Google Scholar • Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit